Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers.

Sengsayadeth SM, Jagasia M, Engelhardt BG, Kassim A, Strickland SA, Goodman S, Lucid C, Vnencak-Jones CL, Greer JP, Savani BN
Bone Marrow Transplant. 2012 47 (12): 1535-7

PMID: 22659680 · DOI:10.1038/bmt.2012.88

MeSH Terms (20)

Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Biomarkers, Tumor Combined Modality Therapy Female fms-Like Tyrosine Kinase 3 Humans Leukemia, Myeloid, Acute Male Middle Aged Mutation Prognosis Stem Cell Transplantation Survival Analysis Tandem Repeat Sequences Transplantation, Homologous Treatment Outcome Young Adult

Connections (3)

This publication is referenced by other Labnodes entities:

Links